Home
Exai Bio, Inc.

Exai Bio, Inc. Market Share Analysis for June 2026

Stay informed with the latest breakthroughs from Exai, leveraging oncRNA technology with A.I. to provide actionable insights into cancer biology.

Industry: N/A

Domainexai.bio

Year Founded2021

Employees51 - 200

Annual Revenue$2M - $5M

Exai Bio, Inc.

Exai Bio, Inc. (including company regionals)

exai.bio

See more website traffic and engagement information

Exai Bio, Inc. Revenue up to June 2026 is 2M - 5M

revenue generated by Exai Bio, Inc. top domains

Exai Bio, Inc. top domains revenue over 3 years

Revenue for Exai Bio, Inc. top domains

exai.bio2M - 5M

See more with Sales Intelligence

Total visits to Exai Bio, Inc.'s top domains

Understand Exai Bio, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

exai.bio3.8K

See more with Sales Intelligence

Avg. visit duration in Exai Bio, Inc.'s top domains

Analyze Exai Bio, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

exai.bio00:00:30

See more with Sales Intelligence

Avg. pageviews on Exai Bio, Inc.'s top domains

See how Exai Bio, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

exai.bio1.83

See more with Sales Intelligence

Exai Bio, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Exai Bio, Inc.

These are the website technologies, by industry, used by Exai Bio, Inc. top domains

Content Management System (2)

WebFlow

Email Services (2)

G Suite

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Exai Bio, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsExai Bio Inc. hired Karen E. Knudsen as Board of directors on Dec 5th '24.Exai Bio appoints oncology leader and former American Cancer Society CEO, Karen E. Knudsen, MBA, PhD, to its Board of directors.

NewsExai Bio Inc. hires Dave Daly as Chief Executive Officer.Exai Bio appoints Dave Daly as Chief Executive Officer.

NewsExai Bio Inc. launched AI-driven liquid biopsy platform can detect breast cancer at the earliest stages on Dec 6th '23.Exai Bio, a leader in healthcare innovation, announced groundbreaking data showcasing the efficacy of its novel RNA-based and AI-driven liquid biopsy platform in detecting breast cancer at its earliest stages.